Key result
Education and EHR adaptations are linked to decreased indiscriminate POC troponin testing and ~$669,000 annual savings.
Why the study?
Point-of-care troponins have shown inconsistent accuracy compared to laboratory testing, and inappropriate use to rule out acute coronary syndrome can lead to premature diagnostic closure.
Does a quality improvement initiative reduce indiscriminate point-of-care troponin testing and costs in ED patients evaluated for ACS?
Observational
Does a quality improvement initiative reduce indiscriminate point-of-care troponin testing and costs in ED patients evaluated for ACS?
A quality improvement initiative successfully reduced indiscriminate point-of-care troponin testing, leading to significant cost savings and optimized disposition times despite longer laboratory turnaround times.
May inform local QI to reduce overtesting; leaves open generalizability and effects on outcomes.
No takes yet. Share an insight, caveat, or question.
Grabinski et al. (2025) conducted an observational in Acute coronary syndrome (ACS). Quality improvement initiative (education and EHR adaptations) vs. Pre-initiative was evaluated on Test frequency, turnaround time (TAT), cost, and time to disposition (TTD). A quality improvement initiative using education and EHR adaptations decreased indiscriminate point-of-care troponin testing and reduced annual testing costs by $668,827.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: